almagate has been researched along with Cardiovascular Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chong, NV; Morjaria, R | 1 |
| Losada, M; Manresa, N; Mulero, J; Zafrilla, P | 1 |
| Ballas, ZK; Hare, ND | 1 |
1 review(s) available for almagate and Cardiovascular Diseases
| Article | Year |
|---|---|
Pharmacokinetic evaluation of pegaptanib octasodium for the treatment of diabetic edema.
Topics: Animals; Aptamers, Nucleotide; Cardiovascular Diseases; Diabetic Retinopathy; Humans; Macular Degeneration; Macular Edema; Risk Factors; Vascular Endothelial Growth Factor A; Vision Disorders | 2014 |
2 other study(ies) available for almagate and Cardiovascular Diseases
| Article | Year |
|---|---|
Influence of anti-VEGF about cardiovascular biomarkers in age related macular degeneration.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Atherosclerosis; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Homocysteine; Humans; Lipids; Macular Degeneration; Male; Middle Aged; Ranibizumab; Risk Factors; Vascular Endothelial Growth Factor A; Wet Macular Degeneration | 2015 |
Effectiveness of delayed epinephrine in anaphylaxis.
Topics: Aged, 80 and over; Anaphylaxis; Anticoagulants; Aptamers, Nucleotide; Bronchodilator Agents; Cardiovascular Diseases; Epinephrine; Eye Diseases; Heart Transplantation; Heparin; Humans; Injections, Intramuscular; Male; Middle Aged; Time Factors | 2007 |